Emerging drugs for the treatment of adult MOG-IgG-associated diseases

Expert Opin Emerg Drugs. 2021 Jun;26(2):75-78. doi: 10.1080/14728214.2021.1919082. Epub 2021 Apr 25.

Authors

Edgar Carnero Contentti¹, Mariano Marrodan², Jorge Correale²

Affiliations

¹ Neuroimmunology Unit, Department of Neuroscience, Hospital Alemán, Buenos Aires, Argentina.
² Department of Neurology, Fleni, Buenos Aires, Argentina.

PMID: 33861167
DOI: 10.1080/14728214.2021.1919082

No abstract available

Keywords: MOG-IgG; MOG-associated disease; adults; management; treatment.

Publication types

Editorial

MeSH terms

Adult
Drug Design*
Humans
Immunoglobulin G / immunology*
Myelin-Oligodendrocyte Glycoprotein / immunology*

Substances

Immunoglobulin G
MOG protein, human
Myelin-Oligodendrocyte Glycoprotein